Tenaya Therapeutics to participate in September investor conferences
Tenaya Therapeutics announced it will participate in upcoming September investor conferences. The company is a clinical-stage biotech focused on therapies targeting heart disease underlying causes.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.